Whalegun
Home

James R. Kasinger, General Counsel and Secretary: Crispr Therapeutics CRSP Sell · Filed 09/24

Trade details

Type
Insider sale
Amount
$626,459.6
Shares · price
10,400 sh · $60.24 a share
Held after
94,784 sh
Stock
Crispr Therapeutics CRSP
Person
James R. KasingerGeneral Counsel and Secretary
Trade date
26/09/22
Filed
26/09/24
Days to filing
2 days

Sold 9.9% of holdings

Share of holding sold
9.9%

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 08/23~10/22

James R. Kasinger's recent trades

  • James R. Kasinger

    Planned sale10b5-1 planCrispr Therapeutics

    $626.5K

    Filed 09/22

  • James R. Kasinger

    SellCrispr Therapeutics

    $148.9K

    Filed 03/24

  • James R. Kasinger

    SellCrispr Therapeutics

    $166.5K

    Filed 03/17

  • James R. Kasinger

    SellCrispr Therapeutics

    $147.8K

    Filed 03/12

  • James R. Kasinger

    SellCrispr Therapeutics

    $111K

    Filed 02/20

James R. Kasinger, General Counsel — sold $626.5K of Crispr Therapeutics CRSP · 9.9% of holdings · 10b5-1 plan | Whalegun